Cuproptosis in cancer therapy: mechanisms, therapeutic application and future prospects
Authors:
- 30 October 2024
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 12 (47) , 12191-12206
Abstract
Cuproptosis is a regulated form of cell death induced by the accumulation of metal ions and is closely linked to aspects of cellular drug resistance, cellular metabolism, and signalling pathways.Keywords
Funding Information
- Natural Science Foundation of Anhui Province (2308085QH243)
- Wannan Medical College (YR202209)
This publication has 116 references indexed in Scilit:
- Biomimetic Nano‐Regulator that Induces Cuproptosis and Lactate‐Depletion Mediated ROS Storm for Metalloimmunotherapy of Clear Cell Renal Cell CarcinomaAdvanced Healthcare Materials, 2024
- Mitochondrial‐Targeted Copper Delivery for Cuproptosis‐Based Synergistic Cancer TherapyAdvanced Healthcare Materials, 2024
- Multifaceted Roles of Copper Ions in Anticancer NanomedicineAdvanced Healthcare Materials, 2023
- Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD‐L1 for Enhanced Cancer ImmunotherapyAdvanced Materials, 2023
- An Enzyme‐Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis‐Based Synergistic Cancer TherapyAdvanced Materials, 2022
- Diagnosis and Treatment of Myelodysplastic SyndromesJAMA, 2022
- Elesclomol induces copper‐dependent ferroptosis in colorectal cancer cells via degradation of ATP7AMolecular Oncology, 2021
- Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer TherapyAdvanced Materials, 2021
- The Coppery Age: Copper (Cu)‐Involved NanotheranosticsAdvanced Science, 2020
- Ligand‐Installed Nanocarriers toward Precision TherapyAdvanced Materials, 2019